ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 37 filers reported holding ARGOS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $23,000 | -50.0% | 129,046 | 0.0% | 0.00% | – |
| Q2 2017 | $46,000 | -35.2% | 129,046 | -18.2% | 0.00% | – |
| Q1 2017 | $71,000 | -90.5% | 157,707 | +3.0% | 0.00% | – |
| Q4 2016 | $750,000 | +1.9% | 153,065 | +3.3% | 0.00% | – |
| Q3 2016 | $736,000 | +29.6% | 148,230 | +59.9% | 0.00% | – |
| Q2 2016 | $568,000 | +82.1% | 92,713 | +89.8% | 0.00% | – |
| Q1 2016 | $312,000 | +200.0% | 48,851 | +7.9% | 0.00% | – |
| Q4 2015 | $104,000 | -52.5% | 45,292 | +0.3% | 0.00% | – |
| Q3 2015 | $219,000 | -28.9% | 45,170 | +0.3% | 0.00% | – |
| Q2 2015 | $308,000 | -23.0% | 45,048 | +0.1% | 0.00% | – |
| Q1 2015 | $400,000 | +5.3% | 44,987 | +18.2% | 0.00% | – |
| Q4 2014 | $380,000 | 0.0% | 38,050 | +0.5% | 0.00% | – |
| Q3 2014 | $380,000 | +128.9% | 37,867 | +82.2% | 0.00% | – |
| Q2 2014 | $166,000 | -29.7% | 20,784 | -12.1% | 0.00% | – |
| Q1 2014 | $236,000 | – | 23,648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 241,512 | $1,201,000 | 0.36% |
| WALL STREET ASSOCIATES | 185,097 | $920,000 | 0.31% |
| WASATCH ADVISORS LP | 3,228,741 | $16,047,000 | 0.24% |
| ALTRINSIC GLOBAL ADVISORS LLC | 172,505 | $857,000 | 0.03% |
| Dynamic Technology Lab Private Ltd | 19,007 | $94,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 121,524 | $604,000 | 0.01% |
| Alyeska Investment Group, L.P. | 200,000 | $994,000 | 0.01% |
| Acrospire Investment Management LLC | 2,100 | $10,000 | 0.01% |
| Alyeska Investment Group, L.P. | 111,424 | $554,000 | 0.01% |
| Advisor Group, Inc. | 13,500 | $67,000 | 0.00% |